Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIFI with ICG for Pulmonary Nodules
NCT02851368Phase 1Completed
- Sponsor
- University of Pittsburgh
- Start
- Nov 2016
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of indocyanine green in Pulmonary nodule, sponsored by University of Pittsburgh. Primary endpoints: Visibility in situ, white light at 1 year, Visibility in situ, fluorescence at 1 year and 1 more. Started Nov 2016; status: completed.
02
Drugs
indocyanine green
03
Conditions
Pulmonary nodule
Beyond the preview
Go deeper on NCT02851368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02851368.